Analyzing the coronary heart disease mortality decline in a mediterranean population: Spain 1988-2005;Análisis de la disminución de la mortalidad por enfermedad coronaria en una población mediterránea: España 1988-2005

Revista Espanola de Cardiologia

Volumn 64, Issue 11, 2011, Pages 988-996

  Flores Mateo, Gemma ^a,b   Grau, María ^c   O'Flaherty, Martin ^d   Ramos, Rafel ^a,e   Elosua, Roberto ^c,f   Violan Fors, Concepción ^a   Quesada, Miquel ^a,e   Martí, Ruth ^a,e   Sala, Joan ^g   Marrugat, Jaume ^c   Capewell, Simon ^d  

^a INSTITUT UNIVERSITARI D'INVESTIGACIÓ EN ATENCIÓ PRIMÀRIA JORDI GOL   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e Institut Catal de la Salut   (Spain)

^f CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^g HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

Coronary disease; Drugs; Mortality; Population; Risk factors

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; FEMALE; HEALTH SURVEY; HEART FAILURE; HUMAN; ISCHEMIC HEART DISEASE; LONGITUDINAL STUDY; MALE; META ANALYSIS (TOPIC); MORTALITY; OBESITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECONDARY PREVENTION; SEX DIFFERENCE; SMOKING; SPAIN; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; CARDIAC SURGICAL PROCEDURES; CARDIOVASCULAR AGENTS; CORONARY DISEASE; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; RISK FACTORS; SECONDARY PREVENTION; SPAIN;

EID: 80054981879     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2011.05.033     Document Type: Article

References (44)

1. J. Ferrieres The French paradox: lessons for other countries Heart 90 2004 107 111 (Pubitemid 38064560)
2. R. Masia, A. Pena, J. Marrugat, J. Sala, J. Vila, and M. Pavesi High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. REGICOR Investigators J Epidemiol Community Health 52 1998 707 715 (Pubitemid 28491029)
3. National Statistics Health. Health. Death Statistics according to cause of death. Madrid: INE; 2009 [actualizado 6 Abr 2009; citado 18 Sep 2009]. Disponible en: http://www.ine.es
4. M. Grau, I. Subirana, R. Elosua, P. Solanas, R. Ramos, and R. Masiá Trends in cardiovascular risk factor prevalence (1995-2000-2005) in northeastern Spain Eur J Cardiovasc Prev Rehabil 14 2007 653 659 (Pubitemid 47556402)
5. M. Gil, H. Martí, R. Elosúa, M. Grau, J. Sala, and R. Masiá Análisis de la tendencia en la letalidad, incidencia y mortalidad por infarto de miocardio en Girona entre 1990 y 1999 Rev Esp Cardiol 60 2007 349 356 (Pubitemid 46881540)
6. E.S. Ford, U.A. Ajani, J.B. Croft, J.A. Critchley, D.R. Labarthe, and T.E. Kottke Explaining the decrease in U.S. deaths from coronary disease, 1980-2000 N Engl J Med 356 2007 2388 2398 (Pubitemid 46883773)
7. T. Laatikainen, J. Critchley, E. Vartiainen, V. Salomaa, M. Ketonen, and S. Capewell Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997 Am J Epidemiol 162 2005 764 773 (Pubitemid 41437763)
8. S. Capewell, R. Beaglehole, M. Seddon, and J. McMurray Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993 Circulation 102 2000 1511 1516
9. B. Unal, J.A. Critchley, and S. Capewell Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000 Circulation 109 2004 1101 1107 (Pubitemid 38332613)
10. L. Bjorck, A. Rosengren, K. Bennett, G. Lappas, and S. Capewell Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002 Eur Heart J 30 2009 1046 1056
11. J. Critchley, J. Liu, D. Zhao, W. Wei, and S. Capewell Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999 Circulation 110 2004 1236 1244 (Pubitemid 39202339)
12. L. Palmieri, K. Bennett, S. Giampaoli, and S. Capewell Explaining the decrease in coronary heart disease mortality in Italy between 1980 and 2000 Am J Public Health 100 2010 684 692
13. I. Ferreira-González, G. Permanyer-Miralda, J. Marrugat, M. Heras, J. Cunat, and E. Civeira Estudio MASCARA (Manejo del Síndrome Coronario Agudo, Registro Actualizado). Resultados globales Rev Esp Cardiol 61 2008 803 816
14. J. Mant, and N. Hicks Detecting differences in quality of care: the sensitivity of measures of process and outcome in treating acute myocardial infarction BMJ 311 1995 793 796
15. J. Butler, P.G. Arbogast, R. BeLue, J. Daugherty, M.K. Jain, and W.A. Ray Outpatient adherence to beta-blocker therapy after acute myocardial infarction J Am Coll Cardiol 40 2002 1589 1595 (Pubitemid 35253636)
16. M.B. Nichol, F. Venturini, and J.C. Sung A critical evaluation of the methodology of the literature on medication compliance Ann Pharmacother 33 1999 531 540 (Pubitemid 29255059)
17. S. Lewington, R. Clarke, N. Qizilbash, R. Peto, and R. Collins Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies Lancet 360 2002 1903 1913 (Pubitemid 35472129)
18. K. Rothman, and S. Greenland Modern epidemiology 2nd ed. 1998 Lippincott-Raven Philadelphia
19. A. Briggs, M. Sculpher, and M. Buxton Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis Health Econ 3 1994 95 104
20. W.J. Rogers, J.G. Canto, C.T. Lambrew, A.J. Tiefenbrunn, B. Kinkaid, and D.A. Shoultz Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3 J Am Coll Cardiol 36 2000 2056 2063
21. Instituto de Salud Carlos III [página de Internet]. Madrid: ISCIII; 2009 [citado 18 Sep 2009]. Disponible en: http://193.146.50.130/raziel. php
22. E. Abu-Assi, J.M. García-Acuña, C. Pena-Gil, and J.R. González-Juanatey Validación en una cohorte contemporánea de pacientes con síndrome coronario agudo del score GRACE predictor de mortalidad a los 6 meses de seguimiento Rev Esp Cardiol 63 2010 640 648
23. Tolonen H, Kuulasmaa K, Ruokokoski E, WHO MONICA Project. MONICA Population Survey Data Book [citado 25 Sep 2009]. Disponible en: http://www.ktlfi/publications/monica/
24. B.J. Banegas Epidemiologia de la hipertensión arterial en España. Situación actual y perspectivas Hipertension 22 2005 353 362
25. D.K. Arnett, D.R. Jacobs Jr., R.V. Luepker, H. Blackburn, C. Armstrong, and S.A. Claas Twenty-year trends in serum cholesterol, hypercholesterolemia, and cholesterol medication use: the Minnesota Heart Survey, 1980-1982 to 2000-2002 Circulation 112 2005 3884 3891 (Pubitemid 43739486)
26. M.D. Carroll, D.A. Lacher, P.D. Sorlie, J.I. Cleeman, D.J. Gordon, and M. Wolz Trends in serum lipids and lipoproteins of adults, 1960-2002 JAMA 294 2005 1773 1781 (Pubitemid 41434623)
27. P. Marques-Vidal, J.B. Ruidavets, P. Amouyel, P. Ducimetiere, D. Arveiler, and M. Montaye Change in cardiovascular risk factors in France, 1985-1997 Eur J Epidemiol 19 2004 25 32 (Pubitemid 38250050)
28. Encuestas Nacionales de Salud de España de años anteriores [citado 14 Sep 2009]. Disponible en: http://www.msc.es/estadEstudios/ estadisticas/encuestaNacional/aniosAnteriores.htm
29. J.M. Martínez-Sánchez, E. Fernández, M. Fu, M. Pérez-Ríos, M.J. López, and C. Ariza Impact of the Spanish smoking law in smoker hospitality workers Nicotine Tob Res 11 2009 1099 1106
30. M. Nebot, Z. Tomás, M.J. López, C. Ariza, E. Díez, and C. Borrell Cambios en el consumo de tabaco en la población general en Barcelona, 1983-2000 Aten Primaria 34 2004 457 462 (Pubitemid 40095050)
31. Serra Majem L, Ribas L. Tendncies d'obesitat, hbits alimentaris i de l'activitat física a Catalunya a partir de les enquestes catalanes, i l'anlisi de les tendncies de sobreps en la infncia i l'adolescncia a partir de diverses enquestes nacionals. [consultado 12 Nov 2009]. Fundació per a la Investigació Nutricional. 2009. Disponible en: http://www.gencat.cat/ salut/depsalut/html/ca/dir2649/tenobesi2011.pdf
32. K. Cooper, R. Davies, P. Roderick, D. Chase, and J. Raftery The development of a simulation model of the treatment of coronary heart disease Health Care Manag Sci 5 2002 259 267 (Pubitemid 41450971)
33. K. Wolf-Maier, R.S. Cooper, H. Kramer, J.R. Banegas, S. Giampaoli, and M.R. Joffres Hypertension treatment and control in five European countries, Canada, and the United States Hypertension 43 2004 10 17 (Pubitemid 38031904)
34. L.J. Shaw, D.S. Berman, D.J. Maron, G.B. Mancini, S.W. Hayes, and P.M. Hartigan Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy Circulation 117 2008 1283 1291 (Pubitemid 351365675)
35. E. Vartiainen, P. Puska, J. Pekkanen, J. Tuomilehto, and P. Jousilahti Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland BMJ 309 1994 23 27 (Pubitemid 24202635)
36. M.L. Bots, and D.E. Grobbee Decline of coronary heart disease mortality in The Netherlands from 1978 to 1985: contribution of medical care and changes over time in presence of major cardiovascular risk factors J Cardiovasc Risk 3 1996 271 276 (Pubitemid 26264426)
37. J.M. Baena Díez, J.L. del Val García, P.J. Tomás, J.L. Martínez Martínez, P.R. Martín, and T. González Epidemiología de las enfermedades cardiovasculares y factores de riesgo en atención primaria Rev Esp Cardiol 58 2005 367 373
38. Countrywide Integrated Noncommunicable Diseases Intervention (CINDI) programme [citado 14 Sep 2009]. Disponible en: http://www.wip.villa-bosch.de/
39. L.M. León, E.M. Andrés, A. Cordero, I. Pascual, C. Vispe, and M. Laclaustra Relación entre el síndrome metabólico y la mortalidad por cardiopatía isquémica en España Rev Esp Cardiol 62 2009 1469 1472
40. M. Grau, R. Elosua, A. Cabrera de León, M.J. Guembe, J.M. Baena-Díez, and A.T. Vega Factores de riesgo cardiovascular en España en la primera década del siglo xxi: análisis agrupado con datos individuales de 11 estudios de base poblacional, estudio DARIOS Rev Esp Cardiol 64 2011 295 304
41. S. Valdés, P. Botas, E. Delgado, and C.F. Díaz Riesgo de mortalidad en diabetes diagnosticada, diabetes no diagnosticada y prediabetes en población adulta española. Estudio Asturias 1998-2004 Rev Esp Cardiol 62 2009 528 534
42. A. Heiat, C.P. Gross, and H.M. Krumholz Representation of the elderly, women, and minorities in heart failure clinical trials Arch Intern Med 162 2002 1682 1688
43. F.A. McAlister Commentary: relative treatment effects are consistent across the spectrum of underlying risks usually Int J Epidemiol 31 2002 76 77 (Pubitemid 34284904)
44. J. Hippisley-Cox, M. Pringle, N. Crown, A. Meal, and A. Wynn Sex inequalities in ischaemic heart disease in general practice: cross sectional survey BMJ 322 2001 832